In the present study we characterized the EpCAM+ cells for their cancer stem cell properties in vitro and evaluated EpCAM co-expression with cancer stem cell-like markers, such as cluster determinant (CD)44, CD24, and ABCG2, in fresh primary retinoblastoma tumors. This evidence concerns the gene ABCG2 and retinoblastoma.